Ignite Creation Date:
2024-05-06 @ 1:13 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01767714
Status:
COMPLETED
Last Update Posted:
2014-12-09
First Post:
2012-12-17
Brief Title:
Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5106CD34 Cellskg in Non-Hodgkins Lymphoma NHL Patients for Autologous Transplantation
Sponsor:
Organization:
Sanofi
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
100
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: